Skip to main content

Keyboard Shortcuts

Key Pair Function
Alt S Search Box
Alt T Top of Page
Alt H Home Page
Alt Index Button
Alt Next Button
Alt Prev Button
A4TE Logo

A4TE's Trans Health Project

Working for Transgender Equal Rights
Menu
  • Trans Health Insurance Tutorial
    • Choosing a Plan
    • Understanding Your Plan
    • Applying for Coverage
    • Understanding a Denial
    • Appealing a Denial
  • About Us
    • About A4TE's Trans Health Project
    • Privacy Policy
  • Contact Us
    • Contact A4TE
    • Contact A4TE's Trans Health Project
  • Resources
    • Legal Analysis
    • Medical Necessity Literature Reviews
    • Reporting Medical Provider Discrimination
    • Training Materials for Advocates
    • Provider Medical Necessity Letter Checklists
    • Health Insurance Medical Policies
    • Medical Organization Statements
    • State Health Insurance Laws and Guidance
    • Medicaid Regulations and Guidance
    • Gender Centers
    • Finding Trans Health Care Providers
    • State Employee Health Plans
    • Financial Aid for Transgender Surgeries
    • Gender Affirming Surgery Appeal Template
  • Tutorial del Seguro de Salud Trans
    • Cómo elegir un plan
    • Cómo entender su plan
    • Cómo solicitar cobertura
    • Cómo entender una denegación
    • Cómo apelar una denegación
Previous Page
Prev
Home
Home
Up
Up
Next Page
Next
  •  Home
  • Resources
  • Health Insurance Medical Policies
  • Current: Independence Blue Cross - Treatment of Gender Dysphoria

Prev Index Gender Dysphoria/Reassignment [101 of 162] Next

Independence Blue Cross

Treatment of Gender Dysphoria


Policy: Treatment of Gender Dysphoria
Policy Number: 11.09.02h
Last Update: 2020-01-01
Issued in: Pennsylvania

Body Contouring:

POTENTIALLY COSMETIC

The following procedures are considered potentially cosmetic services, unless medical necessity demonstrating a functional impairment can be identified. Services that are cosmetic are a benefit contract exclusion for all products of the Company, and therefore, not eligible for reimbursement consideration. This is not an all-inclusive list, refer to any applicable medical policies.

  • Abdominoplasty
  • Blepharoplasty
  • Body contouring procedures (e.g., liposuction, lipectomy)
  • Botox injections
  • Calf implantation
  • Cervicoplasty/platysmaplasty
  • Chin augmentation (genioplasty, mentoplasty)
  • Collagen injections
  • Dermabrasions/chemical peels
  • Excision of redundant skin
  • Facial masculinizing/feminizing surgeries (e.g., facial bone reduction)
  • Facial prosthesis (e.g. nasal, orbital)
  • Forehead reduction
  • Gluteal augmentation (e.g., silicone implants, fat transfer, fat grafting)
  • Hair reconstruction (e.g. hair removal/electrolysis, hair transplantation, wigs)
  • Injectable dermal fillers (e.g., Sculptra, Radiesse)
  • Lip reduction/enhancement
  • Orthognathic procedures
  • Otoplasty
  • Pectoral implantation
  • Rhinoplasty
  • Rhytidectomy
  • Tattooing (non therapeutic)
  • Trachea shave/reduction thyroid chondroplasty
  • Voice therapy, voice modification, laryngoplasty, cricothyroid approximation


REQUIRED DOCUMENTATION

The individual's medical record must reflect the medical necessity for the care provided. These medical records may include, but are not limited to: records from the professional provider's office, hospital, nursing home, home health agencies, therapies, and test reports.

Breast Reconstruction:

Breast augmentation is considered medically necessary and, therefore, covered, when all of the following criteria are met:

  • The individual has persistent, well-documented gender dysphoria in accordance with the criteria established in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, [DSM-5].
  • Breast augmentation is recommended by a qualified professional provider who has consistently monitored the individual up to the time of surgery.
    • One referral letter and/or chart documentation must be written from the mental health professional provider who consistently monitored the individual throughout their psychotherapy or any other evaluation to the professional provider who will be responsible for the individual's treatment.
  • The individual is at least 18 years of age.
  • The individual, unless medically contraindicated, has used feminizing hormones continuously and responsibly (which may include screenings and follow-ups with the professional provider) for a 12-month period.
  • The individual, if required by a mental health professional provider, has regularly participated in psychotherapy throughout the real-life experience at a frequency determined jointly by the individual and the mental health professional provider.
  • If the individual has significant medical or mental health concerns, they are reasonably well controlled.

Youth Services:

Puberty suppressing hormones (e.g., Supprelin LA® [histrelin acetate], Vantas® [histerlin acetate], Lupron Depot® [leuprolide acetate for depot suspension], Viadur® [leuprolide acetate implant], Eligard® [(leuprolide acetate for injectable suspension], Zoladex® [goserelin acetate implant], Trelstar® [triptorelin pamoate for injectable suspension]) are considered medically necessary and, therefore, covered, when all of the following criteria are met:

  • The adolescent has demonstrated a long-lasting and intense pattern of gender nonconformity or gender dysphoria (whether suppressed or expressed), in accordance with criteria established in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, [DSM-5].
  • The individual has reached at least Tanner Stage 2 of development.
  • Gender dysphoria emerged or worsened with the onset of puberty.

Note: Subject to the terms, conditions, and limitations of the member’s contract, oral and self-administered hormones are not covered under the medical benefit.

Back to top

Updated on Nov 14, 2020

Donate Now
Facebook Button Instagram Button
 Keyboard Shortcuts
 Privacy Policy
 A4TE Website

Copyright © 2024 Advocates For Trans Equality, Inc.  |  Tel: (202) 642-4542